About Enteris BioPharma
Enteris BioPharma is a company based in Boonton (United States) founded in 2013 was acquired by SWK Holdings in August 2019.. Enteris BioPharma offers products and services including CMC Consulting, Formulation Development, Spray Drying, and cGMP Manufacturing. Enteris BioPharma operates in a competitive market with competitors including Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others.
- Headquarter Boonton, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Mod3 Pharma, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
Employee Count
-
Acquired by
SWK Holdings
(Aug 27, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Enteris BioPharma
Enteris BioPharma offers a comprehensive portfolio of products and services, including CMC Consulting, Formulation Development, Spray Drying, and cGMP Manufacturing. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Offers expertise in Chemistry, Manufacturing, and Controls for drugs
Develops formulations for challenging active ingredients
Engineers particles for enhanced drug bioavailability
Produces clinical supplies under good manufacturing practices
Unlock access to complete
Unlock access to complete
Funding Insights of Enteris BioPharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Enteris BioPharma
Enteris BioPharma has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include SWK Holdings. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments and advisory services are provided by the holding company.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Enteris BioPharma
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Enteris BioPharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Enteris Biopharma Comparisons
Competitors of Enteris BioPharma
Enteris BioPharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| domain | founded_year | HQ Location |
Dental implants and regenerative dentistry products are developed.
|
|
| domain | founded_year | HQ Location |
RNA-editing technologies are provided for precision medicine applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Enteris Biopharma
Frequently Asked Questions about Enteris BioPharma
When was Enteris BioPharma founded?
Enteris BioPharma was founded in 2013.
Where is Enteris BioPharma located?
Enteris BioPharma is headquartered in Boonton, United States. It is registered at Boonton, New Jersey, United States.
What does Enteris BioPharma do?
Enteris BioPharma specializes in oral peptide delivery and has developed a technology called Peptelligence, which has two components enhancer and excipient. The enhancer acts as a permeation tool and loosens the tight junction of the intestinal enterocytes, whereas the excipient works as a chelating agent, easing the transport and permeating the membrane. The company has two oral drugs in the pipeline based on the above-mentioned technology Ovarest (phase 1 -endometriosis) and Tobrate (preclinical - UTI). Additionally, it provides contract manufacturing from small pre-clinical to commercial scale.
Who are the top competitors of Enteris BioPharma?
Enteris BioPharma's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
What products or services does Enteris BioPharma offer?
Enteris BioPharma offers CMC Consulting, Formulation Development, Spray Drying, and cGMP Manufacturing.
Who are Enteris BioPharma's investors?
Enteris BioPharma has 1 investor. Key investors include SWK Holdings.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.